These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17391962)

  • 41. Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats.
    Rothman RB; Zolkowska D; Baumann MH
    Ann N Y Acad Sci; 2008 Oct; 1139():268-84. PubMed ID: 18991872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.
    Vickers T; Dyck B; Tamiya J; Zhang M; Jovic F; Grey J; Fleck BA; Aparicio A; Johns M; Jin L; Tang H; Foster AC; Chen C
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3230-5. PubMed ID: 18468895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.
    Paudel S; Cao Y; Guo S; An B; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Oct; 23(19):6418-26. PubMed ID: 26337019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleus.
    MacGillivray L; Reynolds KB; Rosebush PI; Mazurek MF
    Synapse; 2012 May; 66(5):465-70. PubMed ID: 22121041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enantioselective synthesis of a highly potent selective serotonin reuptake inhibitor. An application of imidazolidinone catalysis to the alkylation of indoles with an alpha,beta-disubstituted alpha,beta-unsaturated aldehyde.
    King HD; Meng Z; Denhart D; Mattson R; Kimura R; Wu D; Gao Q; Macor JE
    Org Lett; 2005 Aug; 7(16):3437-40. PubMed ID: 16048311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of anti-depressant effects of phthalazinone-based triple-acting small molecules against 5-HT
    Kim J; Cha E; Park WK; Lee HY; Lim SM; Kim HJ; Pae AN
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126882. PubMed ID: 31889666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells.
    Iceta R; Mesonero JE; Alcalde AI
    Life Sci; 2007 Mar; 80(16):1517-24. PubMed ID: 17289086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of an efficient therapeutic agent for Alzheimer's disease: design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter.
    Toda N; Kaneko T; Kogen H
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):273-87. PubMed ID: 20190429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
    Lelas S; Li YW; Wallace-Boone TL; Taber MT; Newton AE; Pieschl RL; Davis CD; Molski TF; Newberry KS; Parker MF; Gillman KW; Bronson JJ; Macor JE; Lodge NJ
    Neuropharmacology; 2013 Oct; 73():232-40. PubMed ID: 23770339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Bhumireddy P; Ortells MO
    Int J Biochem Cell Biol; 2010 May; 42(5):712-24. PubMed ID: 20079457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and functional characterization of the Gulf toadfish serotonin transporter SLC6A4.
    Amador MHB; McDonald MD
    J Exp Biol; 2018 Apr; 221(Pt 7):. PubMed ID: 29487159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.
    Heinrich T; Böttcher H; Schiemann K; Hölzemann G; Schwarz M; Bartoszyk GD; van Amsterdam C; Greiner HE; Seyfried CA
    Bioorg Med Chem; 2004 Sep; 12(18):4843-52. PubMed ID: 15336263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants.
    Baudry A; Mouillet-Richard S; Schneider B; Launay JM; Kellermann O
    Science; 2010 Sep; 329(5998):1537-41. PubMed ID: 20847275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.
    Pechulis AD; Beck JP; Curry MA; Wolf MA; Harms AE; Xi N; Opalka C; Sweet MP; Yang Z; Vellekoop AS; Klos AM; Crocker PJ; Hassler C; Laws M; Kitchen DB; Smith MA; Olson RE; Liu S; Molino BF
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7219-22. PubMed ID: 23084899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
    He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
    J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.
    Vijaya Kumar K; Rudra A; Sreedhara MV; Siva Subramani T; Prasad DS; Das ML; Murugesan S; Yadav R; Trivedi RK; Louis JV; Li YW; Bristow LJ; Naidu PS; Vikramadithyan RK
    Brain Behav Immun; 2014 Nov; 42():204-11. PubMed ID: 25016199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines.
    Mahaney PE; Vu AT; McComas CC; Zhang P; Nogle LM; Watts WL; Sarkahian A; Leventhal L; Sullivan NR; Uveges AJ; Trybulski EJ
    Bioorg Med Chem; 2006 Dec; 14(24):8455-66. PubMed ID: 16973367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.
    Gabrielsen M; Kurczab R; Ravna AW; Kufareva I; Abagyan R; Chilmonczyk Z; Bojarski AJ; Sylte I
    Eur J Med Chem; 2012 Jan; 47(1):24-37. PubMed ID: 22071255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of 2-(4-fluorophenoxy)-2-phenyl-ethyl piperazines as serotonin-selective reuptake inhibitors with a potentially improved adverse reaction profile.
    Dorsey JM; Miranda MG; Cozzi NV; Pinney KG
    Bioorg Med Chem; 2004 Mar; 12(6):1483-91. PubMed ID: 15018922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.